Benzinga | Nov 5, 2021 09:33AM EDT

Cellectis Q3 EPS $(0.71) Beats $(0.83) Estimate, Sales $10.83M Miss $11.14M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.83) by 14.46 percent. This is a 12.7 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $10.83 million which missed the analyst consensus estimate of $11.14 million by 2.81 percent. This is a 17.15 percent increase over sales of $9.24 million the same period last year.